Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alkyl Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110655456A introduces a cobalt-catalyzed method for asymmetric hydrogenation of mixed E/Z olefins. Achieves high enantioselectivity for pharmaceutical intermediates with significant cost advantages.
Patent CN110655456B details Co-catalyzed hydrogenation of E/Z mixed olefins. Offers high ee and conversion for pharmaceutical intermediates.